VON WILLEBRAND DISEASE, TYPE 3
Clinical trials for VON WILLEBRAND DISEASE, TYPE 3 explained in plain language.
Never miss a new study
Get alerted when new VON WILLEBRAND DISEASE, TYPE 3 trials appear
Sign up with your email to follow new studies for VON WILLEBRAND DISEASE, TYPE 3, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New injection aims to stop dangerous bleeds in rare blood disorder
Disease control Recruiting nowThis study is testing if regular injections of a drug called emicizumab can safely prevent bleeding episodes in people with severe Type 3 von Willebrand disease (VWD), a rare disorder where blood doesn't clot properly. It will compare the new injection treatment against current s…
Matched conditions: VON WILLEBRAND DISEASE, TYPE 3
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Apr 04, 2026 03:35 UTC
-
Researchers track bleeding patterns in rare blood disorder patients
Knowledge-focused Recruiting nowThis study aims to gather real-world information about how well standard preventive treatment works for people with severe Type 3 Von Willebrand Disease, a rare bleeding disorder. Researchers will follow 40 patients for at least 24 weeks to track their bleeding episodes and measu…
Matched conditions: VON WILLEBRAND DISEASE, TYPE 3
Sponsor: Hoffmann-La Roche • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:41 UTC